GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020
14 oct. 2020 17h20 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close...
GenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA
08 oct. 2020 16h05 HE
|
GenMark Diagnostics, Inc.
RP2 Panel at a Glance GenMark’s ePlex® Respiratory Pathogen Panel 2 (RP2 Panel) has received Emergency Use Authorization from the FDA.The RP2 Panel provides results in less than two hours for more...
GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020
08 oct. 2020 16h03 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
Le Panel de pathogènes respiratoires 2 (RP2) ePlex de GenMark Diagnostics obtient le marquage CE
15 sept. 2020 09h04 HE
|
GenMark Diagnostics, Inc.
Le test syndromique moléculaire pour la COVID-19, la grippe et d'autres pathogènes respiratoires courants aide les professionnels de santé à se préparer à la saison de la grippe Le Panel RP2 en un...
GenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE Mark
14 sept. 2020 16h05 HE
|
GenMark Diagnostics, Inc.
Molecular syndromic test for COVID-19, influenza and other common respiratory pathogenshelps health care professionals prepare for flu season RP2 Panel at a Glance GenMark’s ePlex® Respiratory...
GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test
17 août 2020 08h00 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that it has...
GenMark Diagnostics Reports Second Quarter 2020 Results
04 août 2020 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
29 juil. 2020 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020
21 juil. 2020 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close...
GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020
07 juil. 2020 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...